The SENTRY Clinical Study

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2018

Conditions
Pulmonary EmbolismDeep Vein Thrombosis
Interventions
DEVICE

SENTRY IVC Filter

The SENTRY IVC Bioconvertible Filter is designed to provide temporary protection to subjects at transient, high risk of pulmonary embolism. Following conclusion of the protection period The SENTRY filter bioconverts, and filter arms withdraw towards the IVC wall for incorporation; obviating the need for retrieval.

Trial Locations (23)

27599

University of North Carolina, Chapel Hill

27607

Rex Hospital, Raleigh

30322

Emory University, Atlanta

32610

University of Florida, Gainesville

35243

Brookwood Medical Center, Birmingham

35294

University of Alabama, Birmingham

43214

Riverside Methodist Hospital, Columbus

43606

Jobst Vascular Institute, Toledo

46202

Indiana University, Indianapolis

60521

Adventist Midwest Health, Hinsdale

61603

St. Francis Hospital, Peoria

63110

Washington University in St Louis, St Louis

70433

Lakeview Regional Heart Center, Covington

75390

University of Texas Southwestern, Dallas

80909

Memorial Health System, Colorado Springs

94305

Stanford Hospital & Clinic, Palo Alto

99204

Providence Medical Research Center, Spokane

06108

Hartford Hospital, Hartford

07103

Rutgers-New Jersey Medical School, Newark

02903

Rhode Island Hospital, Providence

Unknown

Imelda Hospital, Bonheiden

AZ Sint-Blasius, Dendermonde

Pontificia Universidad Catolica De Chile, Santiago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novate Medical

INDUSTRY

lead

Boston Scientific Corporation

INDUSTRY